Search

Your search keyword '"Hepzato (Medication) -- Research -- Reports"' showing total 6 results
Start Over Descriptor "Hepzato (Medication) -- Research -- Reports"
6 results on '"Hepzato (Medication) -- Research -- Reports"'

1. Delcath Systems, Inc. Highlights Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients

Subjects
Delcath Systems Inc. -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Metastasis -- Care and treatment -- Research -- Patient outcomes, Liver cancer -- Care and treatment -- Patient outcomes -- Research, Liver -- Research -- Reports, Melanoma -- Patient outcomes -- Research -- Care and treatment, Arts and entertainment industries, Hepzato (Medication) -- Research -- Reports
Abstract

Delcath Systems, an interventional oncology company specializing in the treatment of primary and metastatic liver cancers, reported the publication of a retrospective study by independent investigators in the Annals of [...]

Published
2024

2. Delcath Systems, Inc. Unveils Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients

Subjects
Delcath Systems Inc. -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Immunotherapy -- Reports -- Research, Liver -- Research -- Reports, Melanoma -- Patient outcomes -- Research -- Care and treatment, Pharmaceutical industry -- Reports -- Research, General interest, News, opinion and commentary, Hepzato (Medication) -- Research -- Reports
Abstract

NEW YORK: Delcath Systems, Inc., announces the publication of a retrospective study by independent investigators in the Annals of Surgical Oncology. The study, titled 'Hepatic and Overall Progression-Free Survival After [...]

Published
2024

3. Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients

Subjects
Delcath Systems Inc. -- Reports, Oncology, Experimental -- Reports, Metastasis -- Care and treatment -- Research, Liver -- Research -- Reports, Liver cancer -- Care and treatment -- Research, Cancer -- Research, Pharmaceutical industry -- Reports -- Research, Business, Business, international, Hepzato (Medication) -- Research -- Reports
Abstract

NEW YORK -- Delcath Systems, Inc. (Nasdaq: DCTH) (the 'Company' or 'Delcath'), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced [...]

Published
2024

4. Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients

Subjects
Delcath Systems Inc. -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Metastasis -- Care and treatment -- Research -- Patient outcomes, Cancer -- Care and treatment, Liver cancer -- Care and treatment -- Patient outcomes -- Research, Liver -- Research -- Reports, Melanoma -- Patient outcomes -- Research -- Care and treatment, Pharmaceutical industry -- Reports -- Research, Business, Business, international, Hepzato (Medication) -- Research -- Reports
Abstract

NEW YORK -- Delcath Systems, Inc. (Nasdaq: DCTH) (the 'Company' or 'Delcath'), an interventional oncology company specializing in the treatment of primary and metastatic liver cancers, today announced the publication [...]

Published
2024

5. Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients

Subjects
Oncology, Experimental -- Reports, Metastasis -- Care and treatment -- Research, Liver -- Research -- Reports, Liver cancer -- Care and treatment -- Research, Cancer -- Research, Business, Health, Health care industry, Hepzato (Medication) -- Research -- Reports
Abstract

2024 SEP 10 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Delcath Systems, Inc. (Nasdaq: DCTH) (the 'Company' or 'Delcath'), an interventional oncology company focused on [...]

Published
2024

6. Delcath Systems, Inc. Highlights Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients

Subjects
Delcath Systems Inc. -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Metastasis -- Care and treatment -- Research -- Patient outcomes, Liver cancer -- Care and treatment -- Research -- Patient outcomes, Liver -- Research -- Reports, Melanoma -- Research -- Patient outcomes -- Care and treatment, Pharmaceutical industry -- Reports -- Research, Business, Business, international, Telecommunications industry, Hepzato (Medication) -- Research -- Reports
Abstract

Delcath Systems, an interventional oncology company specializing in the treatment of primary and metastatic liver cancers, reported the publication of a retrospective study by independent investigators in the Annals of [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results